| Kristopher Thomas Hubbard, OD | |
|
515 Niobrara Ave, Alliance, NE 69301-3421 | |
| (308) 762-3124 | |
| (308) 762-7326 |
| Full Name | Kristopher Thomas Hubbard |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 15 Years |
| Location | 515 Niobrara Ave, Alliance, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467681122 | NPI | - | NPPES |
| 134259627 | Other | NE | RAILROAD MEDICARE GA |
| 06748 | Other | NE | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1321 (Nebraska) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cheyenne Eye Clinic, Llc | 3072865815 | 5 |
News Archive
Manufacturers temperature controlled microscopy, Linkam Scientific Instruments, have been chosen by the Physics Department of the University of Liverpool to study the effects of controlling stresses applied during the growth of collagen secreted from human fibroblast cells. The research goal of Senior Research Assistant, Dr Caroline Smith, and her colleagues at the University of Liverpool is to advance the treatment of tendon injuries by developing a method of growing oriented human collagen.
Primary lung cancer shifts to metastatic disease by suppressing a family of small molecules that normally locks the tumor in a noninvasive state, researchers at The University of Texas M. D. Anderson Cancer Center report in the Sept. 15 edition of Genes and Development.
AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces achievement of a major milestone with the completion of the active treatment portion of its Phase 1 clinical trial with its lead compound, AHRO-001. The Phase 1 study objective is to evaluate the safety, tolerability and pharmacokinetics of AHRO-001 in healthy volunteers. The clinical study is being conducted in Russia with AtheroNova's licensing partner, OOO CardioNova.
DataMotion today announced the company continues to experience rapid growth as a leading health information service provider (HISP) of Direct Secure Messaging for electronic health records (EHR) and HIPAA compliant email encryption. A growing number of EHR system vendors, health information exchanges (HIE) and healthcare providers are selecting both DataMotion Direct and DataMotion SecureMail for their interoperability, scalability and rapid deployment capabilities.
Delegates visiting MR Solutions' new exhibition stand at ISMRM 2015 and SNMMI 2015, in June 2015, were thrilled to see the company's 3T, 4.7T and 7T MRI cryogen-free magnet technology for preclinical imaging.
› Verified 9 days ago
| Provider Name | Cheyenne Eye Clinic |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1720054802 PECOS PAC ID: 2264414846 Enrollment ID: O20040607000953 |
News Archive
Manufacturers temperature controlled microscopy, Linkam Scientific Instruments, have been chosen by the Physics Department of the University of Liverpool to study the effects of controlling stresses applied during the growth of collagen secreted from human fibroblast cells. The research goal of Senior Research Assistant, Dr Caroline Smith, and her colleagues at the University of Liverpool is to advance the treatment of tendon injuries by developing a method of growing oriented human collagen.
Primary lung cancer shifts to metastatic disease by suppressing a family of small molecules that normally locks the tumor in a noninvasive state, researchers at The University of Texas M. D. Anderson Cancer Center report in the Sept. 15 edition of Genes and Development.
AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces achievement of a major milestone with the completion of the active treatment portion of its Phase 1 clinical trial with its lead compound, AHRO-001. The Phase 1 study objective is to evaluate the safety, tolerability and pharmacokinetics of AHRO-001 in healthy volunteers. The clinical study is being conducted in Russia with AtheroNova's licensing partner, OOO CardioNova.
DataMotion today announced the company continues to experience rapid growth as a leading health information service provider (HISP) of Direct Secure Messaging for electronic health records (EHR) and HIPAA compliant email encryption. A growing number of EHR system vendors, health information exchanges (HIE) and healthcare providers are selecting both DataMotion Direct and DataMotion SecureMail for their interoperability, scalability and rapid deployment capabilities.
Delegates visiting MR Solutions' new exhibition stand at ISMRM 2015 and SNMMI 2015, in June 2015, were thrilled to see the company's 3T, 4.7T and 7T MRI cryogen-free magnet technology for preclinical imaging.
› Verified 9 days ago
| Provider Name | Cheyenne Eye Clinic, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1720054802 PECOS PAC ID: 3072865815 Enrollment ID: O20181009003824 |
News Archive
Manufacturers temperature controlled microscopy, Linkam Scientific Instruments, have been chosen by the Physics Department of the University of Liverpool to study the effects of controlling stresses applied during the growth of collagen secreted from human fibroblast cells. The research goal of Senior Research Assistant, Dr Caroline Smith, and her colleagues at the University of Liverpool is to advance the treatment of tendon injuries by developing a method of growing oriented human collagen.
Primary lung cancer shifts to metastatic disease by suppressing a family of small molecules that normally locks the tumor in a noninvasive state, researchers at The University of Texas M. D. Anderson Cancer Center report in the Sept. 15 edition of Genes and Development.
AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces achievement of a major milestone with the completion of the active treatment portion of its Phase 1 clinical trial with its lead compound, AHRO-001. The Phase 1 study objective is to evaluate the safety, tolerability and pharmacokinetics of AHRO-001 in healthy volunteers. The clinical study is being conducted in Russia with AtheroNova's licensing partner, OOO CardioNova.
DataMotion today announced the company continues to experience rapid growth as a leading health information service provider (HISP) of Direct Secure Messaging for electronic health records (EHR) and HIPAA compliant email encryption. A growing number of EHR system vendors, health information exchanges (HIE) and healthcare providers are selecting both DataMotion Direct and DataMotion SecureMail for their interoperability, scalability and rapid deployment capabilities.
Delegates visiting MR Solutions' new exhibition stand at ISMRM 2015 and SNMMI 2015, in June 2015, were thrilled to see the company's 3T, 4.7T and 7T MRI cryogen-free magnet technology for preclinical imaging.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristopher Thomas Hubbard, OD Po Box 490, Alliance, NE 69301-0490 Ph: (308) 762-3124 | Kristopher Thomas Hubbard, OD 515 Niobrara Ave, Alliance, NE 69301-3421 Ph: (308) 762-3124 |
News Archive
Manufacturers temperature controlled microscopy, Linkam Scientific Instruments, have been chosen by the Physics Department of the University of Liverpool to study the effects of controlling stresses applied during the growth of collagen secreted from human fibroblast cells. The research goal of Senior Research Assistant, Dr Caroline Smith, and her colleagues at the University of Liverpool is to advance the treatment of tendon injuries by developing a method of growing oriented human collagen.
Primary lung cancer shifts to metastatic disease by suppressing a family of small molecules that normally locks the tumor in a noninvasive state, researchers at The University of Texas M. D. Anderson Cancer Center report in the Sept. 15 edition of Genes and Development.
AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces achievement of a major milestone with the completion of the active treatment portion of its Phase 1 clinical trial with its lead compound, AHRO-001. The Phase 1 study objective is to evaluate the safety, tolerability and pharmacokinetics of AHRO-001 in healthy volunteers. The clinical study is being conducted in Russia with AtheroNova's licensing partner, OOO CardioNova.
DataMotion today announced the company continues to experience rapid growth as a leading health information service provider (HISP) of Direct Secure Messaging for electronic health records (EHR) and HIPAA compliant email encryption. A growing number of EHR system vendors, health information exchanges (HIE) and healthcare providers are selecting both DataMotion Direct and DataMotion SecureMail for their interoperability, scalability and rapid deployment capabilities.
Delegates visiting MR Solutions' new exhibition stand at ISMRM 2015 and SNMMI 2015, in June 2015, were thrilled to see the company's 3T, 4.7T and 7T MRI cryogen-free magnet technology for preclinical imaging.
› Verified 9 days ago
Family Vision Clinic Of Alliance Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1317 W 3rd St, Alliance, NE 69301 Phone: 308-762-4056 Fax: 308-762-4063 | |
Family Vision Clinic Of Alliance Optometrist Medicare: Medicare Enrolled Practice Location: 1317 W 3rd St, Alliance, NE 69301 Phone: 308-762-4056 Fax: 308-762-4063 | |
Alliance Vision Source, P.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 515 Niobrara Ave, Alliance, NE 69301 Phone: 308-762-3124 Fax: 308-762-7326 | |
Dr. Creston Marshall Myers, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1317 W 3rd St, Alliance, NE 69301 Phone: 308-762-4056 Fax: 308-762-4063 | |
Dr. Robert Craig Dietrich, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 515 Niobrara Ave, Alliance, NE 69301 Phone: 308-762-3124 Fax: 308-762-7326 |